Pamela Esposito

Pamela Esposito

Direktör/Styrelseledamot på KYMERA THERAPEUTICS, INC.

Förmögenhet: 103 400 $ per 2026-07-31

52 år
Health Technology
Consumer Services
Health Services

Profil

Dr. Pamela Esposito is an Independent Director at Kymera Therapeutics, Inc. and an Advisor at Atlas Venture Advisors, Inc. She is on the Board of Directors at Kymera Therapeutics, Inc. and Accent Therapeutics, Inc. Dr. Esposito was previously employed as a Chief Business Officer by Replimune Group, Inc., a Chief Business Officer by RA Pharmaceuticals, Inc., a Head-Corporate Development by Angiochem, Inc., a Vice President-Business Development by BioVex Group, Inc., a Principal by BioDuro LLC, and a Principal by Galenea Corp.
She also served on the board at Vion Pharmaceuticals, Inc. and BioDuro (Beijing) Co., Ltd. She received her undergraduate degree from Dartmouth College and a doctorate degree from Tufts University School of Medicine.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-06-24 1 000 ( 0 % ) 103 400 $ 2026-07-31

Aktiva positioner av Pamela Esposito

FöretagPositionStart
KYMERA THERAPEUTICS, INC. Direktör/Styrelseledamot 2020-09-04
Direktör/Styrelseledamot -
Konsult / Rådgivare -

Tidigare kända positioner av Pamela Esposito

FöretagPositionSlut
REPLIMUNE GROUP, INC. Investor Relations Kontakt -
RA PHARMACEUTICALS, INC. Företagsledare/Principal 2015-01-01
Företagsledare/Principal 2013-09-30
Företagsledare/Principal 2011-12-31
Direktör/Styrelseledamot 2009-12-31
Se detaljerna i Pamela Espositos erfarenhet

Pamela Espositos utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

68

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Finance

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Pamela Esposito